Seeing Is Believing
Currently, out of the existing stock ratings of Narumi Nakagiri - 2 which are a Buy (50%), 2 which are a Hold (50%)
Analyst Narumi Nakagiri works at DAIWA and is covering the Healthcare sector with 8 price targets and ratings displayed on 2 stocks.
Narumi Nakagiri's average stock forecast success ratio is 83.33% with an average time for price targets to be met of 91.5 days.
Most recent stock forecast was given on MRK, Merck . at 07-Jul-2022.
Analyst best performing recommendations are on AMGN (AMGEN).
The best stock recommendation documented was for AMGN (AMGEN) at 9/24/2021. The price target of $220 was fulfilled within 108 days with a profit of $16.45 (8.08%) receiving and performance score of 0.75.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
260
$-9.04 (-3.36%)
260
22 days ago
17/17 (100%)
$43.7 (28.65%)
714
Buy
310
$40.96 (15.22%)
295
1 months 13 days ago
21/24 (87.5%)
$48.4 (31.11%)
728
Hold
223
$-46.04 (-17.11%)
208
1 months 13 days ago
13/17 (76.47%)
$15.67 (12.28%)
414
Hold
253
$-16.04 (-5.96%)
254
1 months 23 days ago
12/12 (100%)
$9.5 (5.69%)
190
Buy
280
$10.96 (4.07%)
280
2 months 2 days ago
13/21 (61.9%)
$44.69 (20.29%)
572
What Year was the first public recommendation made by Narumi Nakagiri?